A Study to Test Different Doses of Obrixtamig in Patients With Small Cell Lung Cancer and Other Neuroendocrine Tumours That Are Positive for DLL3
A Study to Test Different Doses of Obrixtamig in Patients With Small Cell Lung Cancer and Other Neuroendocrine Tumours That Are Positive for DLL3
Active, not recruiting · NCT04429087 · Registry updated 2026-09-21Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Test Different Doses of Obrixtamig in Patients With Small Cell Lung Cancer and Other Neuroendocrine Tumours That Are Positive for DLL3 | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm, small cell lung carcinoma | Active, not recruiting | Phase 1 | 2026-09-21 | NCT04429087 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Boehringer Ingelheim | 158 |
12 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Clínica Universidad de Navarra | Pamplona | Spain | 12 |
| Hospital Clinico Universitario de Valencia | Valencia | Spain | 109 |
| Hospital Del Mar | Barcelona | Spain | 98 |
| Hospital Universitari Vall d'Hebron | Barcelona | Spain | 200 |
| National Cancer Center Hospital East | Chiba, Kashiwa | Japan | 13 |
| Technische Universität Dresden | Dresden | Germany | 12 |
| University of Maryland School of Medicine | Baltimore | United States | 30 |
| University of Pittsburgh Medical Center | Pittsburgh | United States | 63 |
| Universitätsklinikum Köln (AöR) | Cologne | Germany | 13 |
| Universitätsklinikum Würzburg AÖR | Würzburg | Germany | 7 |
| Washington University School of Medicine | St Louis | United States | 26 |
| Winship Cancer Institute | Atlanta | United States | 28 |